Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, February 12, 2021
Aerami has announced the signing of an exclusive license and development agreement with Hangzhou Chance to develop and commercialize Aerami’s drug device combination product candidate (AER-901).
read more
Friday, February 12, 2021
Metrion Biosciences announced the appointment of John Montana, PhD, as a Non-Executive Director.
read more
Thursday, February 11, 2021
Calyx announced an expansion to its Executive Leadership Team. Richard Wallace joins Calyx as Chief Digital and Information Officer (CDIO).
read more
Thursday, February 11, 2021
RotaChrom Technologies has announced the launch of a collaboration with Cyclolab Cyclodextrin Research and Development Laboratory.
read more
Thursday, February 11, 2021
Active Motif has launched an end-to-end Hi-C service in partnership with Arima Genomics.
read more
Thursday, February 11, 2021
Quotient Sciences has acquired Arcinova, a U.K.-based multiservice CDMO.
read more
Wednesday, February 10, 2021
Avacta and Mologic have entered into a commercial partnership to accelerate to market Avacta’s AffiDX SARS-CoV-2 lateral flow rapid antigen test.
read more
Wednesday, February 10, 2021
AMRI has announced the appointment of Scott Waldman as senior vice president, corporate development.
read more
Wednesday, February 10, 2021
Catalent hadssigned an agreement with Trizell GmbH, to support the manufacturing of Trizell’s Phase 1 cell therapy for the treatment of micro- and macroangiopathies.
read more
Wednesday, February 10, 2021
Alphageneron has signed an Exclusive License Agreement with Multimmune for its clinical stage autologous NK cell therapy and companion diagnostic platform.
read more
Wednesday, February 10, 2021
FairJourney Biologics and IONTAS have announced the launch of a new protein sciences division, Flow Eighteen38.
read more
Wednesday, February 10, 2021
Longevity Acquisition and 4D pharma have announced a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer for BAVENCIO.
read more
Tuesday, February 09, 2021
WuXi STA has agreed to purchase Bristol Myers Squibb’s manufacturing facility in Couvet, Switzerland.
read more
Tuesday, February 09, 2021
Catalent has signed an agreement to provide Decibel Therapeutics with process and analytical development, and CGMP clinical manufacturing services, for Decibel’s lead investigational gene therapy product candidate, DB-OTO.
read more
Tuesday, February 09, 2021
Element has acquired a pharmaceutical analytical testing company, Avomeen, strengthening the Group’s Life Sciences business unit in North America.
read more